The DOI matches its Crossref record; 179 of the 180 references it cites were found in a registry or an index.
Evaluation and management of heart failure with preserved ejection fraction
Abstract
Heart failure with preserved ejection fraction (HFpEF) has grown to become the dominant form of heart failure worldwide, in tandem with ageing of the general population and the increasing prevalences of obesity, diabetes mellitus and hypertension. The clinical syndrome of HFpEF is heterogeneous and must be distinguished from heart failure with reduced ejection fraction as well as other aetiologies that have different treatment strategies. The diagnosis of HFpEF is challenging and ultimately relates to the conceptual definition of heart failure as a clinical syndrome characterized by symptoms that are associated with a reduced capacity of the heart to pump blood adequately at normal filling pressures during diastole. Clinical trials to date have been largely unsuccessful in identifying effective treatments for HFpEF but evidence supports the use of diuretics, mineralocorticoid antagonists and lifestyle interventions. Pathophysiological heterogeneity in the presentation of HFpEF is substantial, and ongoing studies are underway to evaluate the optimal methods to classify patients into phenotypically homogeneous subpopulations to facilitate better individualization of treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Even if the diastolic dysfunction is the hemodynamic feature of HFpEF, the essence of its pathophysiology is the increase of LV filling pressure, meaning that the heart can adequately pump the blood at expense of an elevation of cardiac filling pressures that, if disproportionate during exercise or at rest, are responsible of dyspnea [102,103].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [102]
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,532
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000509 · Cited by 3,109
Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Maurer, M. S., Schwartz, J. H., Gundapaneni, B., Elliott, P. M., Merlini, G., Waddington-Cruz, M., Kristen, A. V., Grogan, M., Witteles, R., Damy, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805689 · Cited by 2,857
Cited by
Sorted by citations
Items 201–300 of 680
In vitro benchtop mock circulatory loop for heart failure with preserved ejection fraction emulation
Malone, A. J., Gallagher, S., Saidi, J., Rizq, G., O’Dowd, E., Vallence, D., & Hameed, A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.910120 · Cited by 15
Gao, Q., He, S., Peng, Y., Su, P., & Zhao, L. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17695 · Cited by 15
Lai, P., Xue, J., Xie, M.-J., Ye, J.-H., Yang, N., Zhong, Y., & Liao, Y.-L. (2023) · Medicine · doi:10.1097/md.0000000000033010 · Cited by 15
Pimentel-Suarez, L. I., & Soto-Mota, A. (2023) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2023-000672 · Cited by 15
Heart Failure With Preserved Ejection Fraction: An Evolving Understanding
Tah, S., Valderrama, M., Afzal, M., Iqbal, J., Farooq, A., Lak, M. A., Gostomczyk, K., Jami, E., Kumar, M., Sundaram, A., et al. (2023) · Cureus · doi:10.7759/cureus.46152 · Cited by 17
Chen, Z., Chung, Y., Cheng, J., Huang, C., Chen, S., Lin, L., Lai, H., & Wu, C. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030025 · Cited by 18
Mu, Y., Yang, Y., Jiang, S., Liu, C., Han, Y., Jiang, J., & Wang, Y. (2024) · Nutrients · doi:10.3390/nu16091273 · Cited by 15
Defining the Phenotypes for Heart Failure With Preserved Ejection Fraction
Rucker, D., & Joseph, J. (2022) · Current Heart Failure Reports · doi:10.1007/s11897-022-00582-x · Cited by 13
Cardiometabolic HFpEF: Mechanisms and Therapies
Schiattarella, G. G., & Hill, J. A. (2021) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2021.1.e18 · Cited by 14
Wang, R., Ye, H., Ma, L., Wei, J., Wang, Y., Zhang, X., & Wang, L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.890481 · Cited by 14
Zhou, H., Zhan, R., Chen, X., Lin, Y.-F., Zhang, S., Zheng, H., Wang, X., Huang, M.-T., Xu, C., Liao, X., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14068 · Cited by 16
Rosalia, L., Öztürk, Ç., Wang, S. X., Quevedo‐Moreno, D. A., Saeed, M. Y., Mauskapf, A., & Roche, E. T. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202310085 · Cited by 18
Pierre‐Jean, M., Marut, B., Curtis, E., Galli, E., Marc Cuggia, A., Bouzillé, G., & Donal, E. (2023) · European Heart Journal Open · doi:10.1093/ehjopen/oead133 · Cited by 14
Impact of ovary-intact menopause in a mouse model of heart failure with preserved ejection fraction
Troy, A. M., Normukhamedova, D., Grothe, D., Momen, A., Zhou, Y., McFadden, M. J., Husain, M., Billia, F., & Cheng, H. M. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00733.2023 · Cited by 14
Ramírez‐Hernández, D., López‐Sánchez, P., Lezama‐Martínez, D., Pérez-García, E., Montoya-Hernández, M. F. S., Aranda‐Fraustro, A., & Flores‐Monroy, J. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2901046 · Cited by 14
Liu, Z., Hu, W., Zhang, H., Tao, H., Peng, L., Liu, J., Yu, Y., Dong, Q., Gao, L., & Zhang, D. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s356001 · Cited by 14
Zheng, W., Qi, Q., Li, J., He, C., & Fan, H. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01917-z · Cited by 17
Echouffo-Tcheugui, J. B., Lewsey, S. C., & Weiss, R. G. (2021) · Journal of Clinical Investigation · doi:10.1172/jci156309 · Cited by 13
Li, S., Zhu, X., Zhang, Y., Li, F., & Guo, S. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14421 · Cited by 13
Naito, A., Obokata, M., Kagami, K., Harada, T., Sorimachi, H., Yuasa, N., Saito, Y., Kato, T., Wada, N., Adachi, T. K., et al. (2023) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2023.101255 · Cited by 13
Pioppi, L., Parvan, R., Samrend, A., da Silva, G. J. J., Paolantoni, M., Sassi, P., & Cataliotti, A. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04465-0 · Cited by 13
Palau, P., de Amo, I., Núñez, G., Flor, C., de la Espriella, R., García-Conejo, C., Berlanga-Tovar, S. E., Casaña, J., Calatayud, J., Domínguez, E., et al. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf269 · Cited by 13
Anderson, T., Hummel, S. L., & Konerman, M. C. (2022) · Cardiology Clinics · doi:10.1016/j.ccl.2022.07.001 · Cited by 14
Imaging for Temporary Mechanical Circulatory Support Devices
Cole, S. P., Martinez-Acero, N., Peterson, A., von Homeyer, P., Gebhardt, B. R., & Nicoara, A. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.09.031 · Cited by 13
Al-U'datt, D. G. F., Tranchant, C. C., Alu'datt, M. H., Abusara, S., Al‐Dwairi, A., Alqudah, M., Al-Shboul, O. A., Hiram, R., Altuntaş, Y., Jaradat, S. A., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121564 · Cited by 12
Guo, H., Zhu, M., Yu, R., Li, X., & Zhao, Q. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1255940 · Cited by 13
Tian, J., Li, W., Zeng, L., Yang, L. H., Du, J., Li, Y., Li, B., & Su, G. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18238 · Cited by 11
Aradhyula, V., Vyas, R., Dube, P. R., Haller, S. T., Gupta, R., Maddipati, K. R., Kennedy, D. J., & Khouri, S. J. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00068.2024 · Cited by 12
Soft robotic platform for progressive and reversible aortic constriction in a small-animal model
Rosalia, L., Wang, S. X., Öztürk, Ç., Huang, W., Bonnemain, J., Beatty, R., Duffy, G. P., Nguyen, C. T., & Roche, E. T. (2024) · Science Robotics · doi:10.1126/scirobotics.adj9769 · Cited by 14
Liu, X., Pan, H., Jiang, Y., Wang, Y., Abudukeremu, A., Cao, Z., Wu, M., He, W., Zhang, M., Yan, Z., et al. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.09.003 · Cited by 12
Predictors and Mortality for Worsening Left Ventricular Ejection Fraction in Patients With HFpEF
Chen, L., Huang, Z., Zhao, X., Liang, J., Lu, X., He, Y., Kang, Y. M., Xie, Y., Liu, J., Liu, Y., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.820178 · Cited by 12
Nguyen, N. D., Tran, T. D., An, P. L., Hoang, S. V., Nguyen, H.-A., & Chau, H. N. (2021) · Cardiology Research and Practice · doi:10.1155/2021/4587678 · Cited by 12
Öztürk, Ç., Rosalia, L., & Roche, E. T. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.815787 · Cited by 11
Ninni, S., Algalarrondo, V., Brette, F., Lemesle, G., & Fauconnier, J. (2024) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2024.02.001 · Cited by 13
Fowler, J. W. M., Song, L., Tam, K., & Flach, R. J. R. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1412857 · Cited by 12
Macrophage energy metabolism in cardiometabolic disease
Wong, A., Sun, Q., Latif, I. I., & Karwi, Q. G. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05099-6 · Cited by 14
Habel, N., Infeld, M. M., Lustgarten, D. L., & Meyer, M. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.08.064 · Cited by 15
Wang, T., Yang, Q., Cheng, X.-Y., Ding, J.-C., & Hu, P.-F. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10438-2 · Cited by 12
Chen, X., Huang, M., Chen, Y., Xu, H., & Wu, M. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10455-1 · Cited by 12
Focusing on microvascular function in heart failure with preserved ejection fraction
Velollari, O., Rommel, K., Kresoja, K., Lurz, P. C., & Gori, T. (2025) · Heart Failure Reviews · doi:10.1007/s10741-024-10479-7 · Cited by 12
The multifaceted role of autophagy and mitophagy in cardiovascular health and disease
Nàger, M., Calvoli, M., Larsen, K. B., & Birgisdottir, Å. B. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2572511 · Cited by 11
Jain, C. C., Pedrotty, D. M., Araoz, P. A., Sugrue, A. M., Vaidya, V. R., Padmanabhan, D., Arunachalam, S. P., Lerman, L. O., Asirvatham, S. J., & Borlaug, B. A. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007530 · Cited by 11
Self-citationPi, Z., Johnson, J. A., Meng, W., Phillips, M. S., Schumacher, W. A., Bostwick, J. S., Gargalovic, P. S., Onorato, J. M., Generaux, C., Wang, T., et al. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00385 · Cited by 11
Pearson, C. R., Forsyth, F., Khair, E., Sowden, E., Boluda, S. B., Deaton, C., Optimise HFpEF Investigators, Chakravorty, M., Maclachlan, S., Kane, E., et al. (2022) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvac027 · Cited by 11
Shi, Y., Liu, J., Liu, C., Xiong, S., Yang, C., Qiao, W., & Dong, G. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.937291 · Cited by 11
Biventricular Cardiac Power Reserve in Heart Failure with Preserved Ejection Fraction
Alogna, A., Omar, M., Popović, D., Sorimachi, H., Omote, K., Reddy, Y. N. V., Pieske, B. M., & Borlaug, B. A. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2867 · Cited by 11
Self-citationBodea, O.-M., Serban, S., Craciun, M.-L., Mateescu, D.-M., Florescu, E., Mureșan, C.-O., Cotet, I.-G., Badalica-Petrescu, M., Munteanu, A. M., Velimirovici, D. E., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15010378 · Cited by 12
Parizad, R., Hatwal, J., Sadeghi, M. T., Brar, A. S., Desai, R., Batta, A., & Mohan, B. (2026) · Vascular Health and Risk Management · doi:10.2147/vhrm.s578698 · Cited by 13
Verwerft, J., Stassen, J., Falter, M., Bekhuis, Y., Hoedemakers, S., Gojevic, T., Ferreira, S. M., Vanhentenrijk, S., Stroobants, S., Jogani, S., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032228 · Cited by 10
Sun, Q., Wagg, C. S., Wong, N. K. P., Wei, K., Ketema, E. B., Zhang, L., Fang, L., Seubert, J. M., & Lopaschuk, G. D. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15319 · Cited by 10
The Cardiomyocyte in Heart Failure with Preserved Ejection Fraction—Victim of Its Environment?
Rocca, A., van Heeswijk, R. B., Richiardi, J., Meyer, P., & Hullin, R. (2022) · Cells · doi:10.3390/cells11050867 · Cited by 10
Wang, Q., Su, H., & Liu, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3617086 · Cited by 10
Heart Failure with Preserved Ejection Fraction: How to Deal with This Chameleon
Lucà, F., Oliva, F. G., Abrignani, M. G., Fusco, S. A. D., Gori, M., Giubilato, S., Ceravolo, R., Temporelli, P. L., Cornara, S., Rao, C. M., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051375 · Cited by 14
Rajanathan, R., Pedersen, T. M., Thomsen, M. B., Bøtker, H. E., & Matchkov, V. V. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.831724 · Cited by 10
Qualitative and Quantitative Effects of Fatty Acids Involved in Heart Diseases
Moriyama, H., Endo, J., Ikura, H., Kitakata, H., Momoi, M., Shinya, Y., Ko, S., Ichihara, G., Hiraide, T., Shirakawa, K., et al. (2022) · Metabolites · doi:10.3390/metabo12030210 · Cited by 10
Swan, J., Szabó, Z., Peters, J., Kummu, O., Kemppi, A., Rahtu‐Korpela, L., Konzack, A., Hakkola, J., Pasternack, A. H., Ritvos, O., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116683 · Cited by 9
Moon, B. F., Zhou, I. Y., Ning, Y., Chen, Y. I., Fur, M. L., Shuvaev, S., Akam, E. A., Ma, H., Solsona, C. M., Weigand‐Whittier, J., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.034363 · Cited by 10
Samani, S. L., Barlow, S. C., Freeburg, L., Catherwood, G., Churillo, A. M., Jones, T. L., Altomare, D., Ji, H., Shtutman, M. S., Zile, M. R., et al. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00551.2023 · Cited by 10
He, J.-K., Jiang, X., Dai, S., Xiaohan, Zhu, Q.-Q., JieYang, Zhang, Y., & Yu, X. (2024) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-024-10569-9 · Cited by 9
Zhou, L., Mei, S., Ma, X., Wuyun, Q., Cai, Z., Chen, C., Ding, H., & Yan, J. (2024) · Epigenomics · doi:10.1080/17501911.2024.2435257 · Cited by 9
Inflammation in Heart Failure: Mechanisms and Therapeutic Strategies
Jiang, Y., Zhou, G., Guo, Y., & Long, Y. (2024) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2024.0050 · Cited by 15
Kagami, K., Kagiyama, N., Kaneko, T., Harada, T., Sato, K., Amano, M., Okada, T., Satô, Y., Ohno, Y., Morita, K., et al. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.132958 · Cited by 9
Chiarito, M., Stolfo, D., Villaschi, A., Sartori, S., Baldetti, L., Lombardi, C., Adamo, M., Loiacono, F., Sammartino, A. M., Riccardi, M., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3585 · Cited by 9
Mesquita, T., Miguel‐dos‐Santos, R., Liu, W., Fournier, M., Rogers, R. G., Alfaro, J., Nawaz, A., Sanchez, L., Jones, X. M., Li, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56186-1 · Cited by 10
Feng, Q., Wu, M., & Mai, Z. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1482918 · Cited by 12
Mahmod, M., Bull, S., Kailayanathan, T., Davis, T. A., Borlotti, A., Popescu, I. A., Das, I., Wamil, M., Thomaides-Brears, H. B., Banerjee, R., et al. (2025) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-025-03455-1 · Cited by 10
Xia, J., Nong, Y., Teng, J., Mohammed, S. A., Liu, J., Pang, Y., Costantino, S., Ruschitzka, F. T., Hamdani, N., Abdellatif, M., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113471 · Cited by 12
Methawasin, M., Meinke, S., Radke, M. H., Farman, G. P., Hourani, Z., Smith, J. E., Guo, W., Granzier, H. L. M., & Gotthardt, M. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf171 · Cited by 9
Wei, H., Zhao, M., Wu, J., Li, C., Huang, M., Gao, J., Zhang, Q., Liang, J., Wang, Y., Zhao, C., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac519 · Cited by 9
Key Phenotypes of Heart Failure with Preserved Ejection Fraction
Kagami, K., Harada, T., Ishii, H., & Obokata, M. (2022) · Cardiology Clinics · doi:10.1016/j.ccl.2022.06.001 · Cited by 9
Dong, X., Xie, Y., Xu, J., Qin, Y., Zheng, Q., Hu, R., Zhang, X., Wang, W., Tian, J., & Yi, K. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13509 · Cited by 10
A narrative review of heart failure with preserved ejection fraction in breast cancer survivors
Yogeswaran, V., Wadden, E., Szewczyk, W., Barac, A., Simon, M. S., Eaton, C. B., Cheng, R. K.-H., & Reding, K. W. (2023) · Heart · doi:10.1136/heartjnl-2022-321859 · Cited by 9
Brooman‐White, R., Blakeman, T., McNab, D., & Deaton, C. (2023) · BMJ Quality & Safety · doi:10.1136/bmjqs-2023-016583 · Cited by 9
Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction
Kim, I. (2021) · Heart Failure Clinics · doi:10.1016/j.hfc.2021.03.001 · Cited by 9
SGLT-2 Inhibitors for Patients with Heart Failure: What Have We Learned Recently?
Rifai, M. A., Newby, L. K., Nair, A. P., Misra, A., Rogers, J. G., Fedson, S., & Virani, S. S. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01038-2 · Cited by 9
Palazzuoli, A., Buono, M. G. D., Ruocco, G. M., Caravita, S., Abbate, A., & Lavie, C. J. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101433 · Cited by 9
Lin, M., Qin, Y., Ding, X., Zhang, M., Zhu, W., Wang, J., Leng, C., Lu, X., & Cai, Q. (2022) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-022-02731-8 · Cited by 9
MicroRNA-19 upregulation attenuates cardiac fibrosis via targeting connective tissue growth factor
Song, X., Cui, Y., & Zhu, T. (2022) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2022.12.010 · Cited by 9
Kubicius, A., Gąsior, Z., & Haberka, M. (2024) · Cardiology Journal · doi:10.5603/cj.95191 · Cited by 8
Tani, Y., Reddy, Y. N. V., Verbrugge, F. H., Yang, J. H., Negishi, K., Harada, T., Kagami, K., Saito, Y., Yuasa, N., Sorimachi, H., et al. (2024) · European Heart Journal - Imaging Methods and Practice · doi:10.1093/ehjimp/qyae059 · Cited by 8
Lai, W., Zhao, X., Gao, Z., Huang, H., Huang, D., Zhou, Y., Liang, G., Chen, S., Liu, J., & Liu, Y. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s462848 · Cited by 9
Meyer, M., Núñez, J. E., Goyal, P., Silverman, D. N., van Berlo, J. H., & Maharaj, V. (2024) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.22 · Cited by 8
Vujić, A., Koo, A., Bidault, G., Miljković, J. L., James, A. M., Dannhorn, A., Duan, X., Davis, L. M., Abe, J., Valadares, J., et al. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00482.2024 · Cited by 8
Duhan, S., Kurpad, K. P., Keisham, B., Shtembari, J., Brener, A., Kanakadandi, U. B., Garg, A., Adoni, N. A., & Mehta, S. S. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133604 · Cited by 8
Bellicini, M. G. (2025) · JACC Case Reports · doi:10.1016/j.jaccas.2025.105594 · Cited by 8
Dakota, I., Wijayanto, M. A., Nugrahani, A. S. D., Sunjaya, A. F., Rachmayanti, S., Indah, E. Y., Naomi, N., Huang, W., Tristan, C. D., Fauziah, M., et al. (2025) · PeerJ · doi:10.7717/peerj.20168 · Cited by 9
Liu, Y., Chen, S., Liu, S., Sun, G., Sun, Z., & Liu, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.950102 · Cited by 8
Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment
Su, M., Hou, Y., Cai, S., Li, W., Wei, Y., Wang, R., Wu, M., Liu, M., Chang, J., Yang, K., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06109-4 · Cited by 8
Chen, Z., Zhu, X.-T., Hu, Z.-P., Ni, J.-X., & Chen, H.-L. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04058-9 · Cited by 8
Lin, H., Hartley, P., Forsyth, F., Pilling, M. A., Hobbs, R. F., Taylor, C. J., Schiff, R., & Deaton, C. (2021) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvab028 · Cited by 7
Liang, B., Liang, Y., & Gu, N. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02693-8 · Cited by 8
Abudoukelimu, M., Ba, B., Guo, Y. K., & Xu, J. (2022) · Medicine · doi:10.1097/md.0000000000029854 · Cited by 8
Hemodynamic Assessment in Heart Failure with Preserved Ejection Fraction
Omote, K., Hsu, S., & Borlaug, B. A. (2022) · Cardiology Clinics · doi:10.1016/j.ccl.2022.06.010 · Cited by 8
Self-citationDong, M., Wang, L., Tse, G., Dai, T., Wang, L., Xiao, Z., Liu, T., & Ren, F. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03048-7 · Cited by 8
Li, J., Qu, X., Gao, Z., Chen, C., Zhang, F.-Y., Cheng, L., Zhou, X., & Zhou, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1084442 · Cited by 9
Diagnostic value of expired gas analysis in heart failure with preserved ejection fraction
Saito, Y., Obokata, M., Harada, T., Kagami, K., Murata, M., Sorimachi, H., Kato, T., Wada, N., Okumura, Y., & Ishii, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-31381-6 · Cited by 8
Leonidou, E., Ioannou, M., Mavrommatis, P. P., & Mouzarou, A. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14415 · Cited by 8
Zhou, G., Chen, J., Wu, C., Jiang, P., Wang, Y., Zhang, Y., Jiang, Y., & Li, X. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.607089 · Cited by 8
Are We Treating Heart Failure in Patients with Chronic Obstructive Pulmonary Disease Appropriately?
Stringer, W. W. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202004-395ed · Cited by 8
Kovács, Á., Zhazykbayeva, S., Herwig, M., Fülöp, G., Csípő, T., Oláh, N., Hassoun, R., Budde, H., Osman, H., Kaçmaz, M., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01160-w · Cited by 6
Metadata
- Authors
- Borlaug, B. A.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Borlaug, Barry A.
- ORCID
- Borlaug, Barry A.
- Venue
- Nature Reviews Cardiology
- Published
- 2020-03-30
- Volume
- 17
- Issue
- 9
- Pages
- 559-573
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W3013711965
- Cited by
- 675
- References
- 180
- Citations by year
- 2026: 97 · 2025: 104 · 2024: 130 · 2023: 132 · 2022: 120 · 2021: 71 · 2020: 19
- FWCI
- 14.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL128526, U01HL125205)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Keywords
- heart failure with preserved ejection fraction, HFpEF diagnosis, diuretics, mineralocorticoid receptor antagonists, lifestyle intervention, phenotypic subgroups, personalized treatment, diastolic dysfunction, aging, obesity, diabetes mellitus, hypertension
- MeSH terms
- Heart Failure, Humans, Middle Aged, Stroke Volume
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
